Consensus Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 12:30:25 2025-03-14 EDT			5-day change	1st Jan Change
96.35 ^CHF	-0.60%		-4.53%	+8.62%

03-14	Novartis Named Official Pharmaceutical Partner of US' National Football League	MT
03-12	Roche ups the ante in obesity

Evolution of the Average Target: Novartis AG

Evolution of the Target Price: Novartis AG

Changes in Analyst Recommendations: Novartis AG

46f35206c96f6d31efbd54cb2baa6.PLx-KZ89k-lS2Gt-bIvQcT4d9K7TKTT-sdxEiuJ2ly8.To0tQq4OypkVnDILVb-aP2RKvsK2ZHyf268m6aAkp0hZxD1e_EXl0BWVAA~57e0ad78ff62acfb91bf7663be23df26

Analysts' recommendations: Novartis AG

NOVARTIS AG : Deutsche Bank reiterates its Buy rating	03-06	ZD
DA Davidson Downgrades Novartis to Neutral From Buy, Price Target is $120	03-04	MT
NOVARTIS AG : JP Morgan is Neutral	02-25	ZD
NOVARTIS AG : Bernstein reiterates its Buy rating	02-20	ZD
NOVARTIS AG : Deutsche Bank keeps its Buy rating	02-18	ZD
NOVARTIS AG : UBS lowers his opinion and switches to Neutral	02-13	ZD
NOVARTIS AG : Gets a Buy rating from Deutsche Bank	02-12	ZD
Morgan Stanley Restarts Novartis Coverage at Underweight	02-12	MT
NOVARTIS AG : Gets a Neutral rating from Goldman Sachs	02-11	ZD
NOVARTIS AG : Goldman Sachs gives a Neutral rating	02-06	ZD
NOVARTIS : 2024 ended on a strong note; 2025 outlook surpassed expectations	02-05
Deutsche Bank Upgrades Novartis to Buy, Lifts PT	02-04	MT
NOVARTIS AG : Deutsche Bank gives a Buy rating	02-04	ZD
NOVARTIS AG : Deutsche Bank reaffirms its Neutral rating	02-03	ZD
NOVARTIS AG : Buy rating from DZ Bank	02-03	ZD
NOVARTIS AG : UBS remains its Buy rating	02-03	ZD
NOVARTIS : UBS reiterates its recommendation on the stock	02-03	CF
NOVARTIS AG : Goldman Sachs reiterates its Neutral rating	01-31	ZD
NOVARTIS AG : UBS gives a Buy rating	01-31	ZD
NOVARTIS : Stifel remains Caution after results	01-31	CF
NOVARTIS AG : Bernstein maintains a Buy rating	01-31	ZD
NOVARTIS AG : Jefferies is Neutral	01-31	ZD
NOVARTIS : Still an attractive proposition for investors, after two healthy years	01-27
NOVARTIS AG : UBS reiterates its Buy rating	01-27	ZD
NOVARTIS AG : Jefferies remains Neutral	01-20	ZD

More recommendations

Sector Comparison:

	Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	4m Revision of opinion	Divergence of analysts' opinions	Divergence of Target Price	Ecart obj. / dr
	NOVARTIS AG					+4.13%
	ELI LILLY AND COMPANY					+23.74%
	JOHNSON & JOHNSON					+3.84%
	ABBVIE INC.					-0.02%
	NOVO NORDISK A/S					+51.1%
	ROCHE HOLDING AG					+3.02%
	MERCK & CO., INC.					+18.73%
	ASTRAZENECA PLC					+16.04%
	AMGEN INC.					+0.71%
	PFIZER, INC.					+21.76%
	Average					+14.31%
	Weighted average by Cap.					+15.91%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

108.90USD

Average target price

113.40USD

Spread / Average Target

+4.13%

High Price Target

137.06USD

Spread / Highest target

+25.85%

Low Price Target

92.84USD

Spread / Lowest Target

-14.75%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
DA Davidson
JPMORGAN	Richard Vosser
BERNSTEIN RESEARCH	Florent Cespedes
UBS	Matthew Weston
Morgan Stanley
GOLDMAN SACHS	James Quigley
alphavalue	Abhishek Raval
DZ BANK	Elmar Kraus
JEFFERIES	Peter Welford
BERENBERG	Luisa Hector
HSBC
Octavian AG
BARCLAYS	Emily Field
Jefferies & Co.
Deutsche Bank Securities
Baader Bank
Berenberg Bank
BMO Capital
Kepler Capital Markets
Societe Generale
Redburn
Stifel Nicolaus
BNP Paribas
Barrington Research
Credit Suisse
International Strategy & Investment Group
Morningstar
ODDO BHF
Zacks Equity Research
Bank of America Securities/Merrill Lynch
Kepler Cheuvreux
Wolfe Research
AltaCorp Capital
DEUTSCHE BANK	Emmanuel Papadakis
Exane BNP Paribas
Bryan, Garnier & Co.
Moody's Investors Service
Dundee
Exane BNP
Bernstein
Argus
Cowen
BRYAN GARNIER	Eric Le Berrigaud
LIBERUM CAPITAL	Graham Doyle
BANK OF AMERICA (BOFA)	Graham Parry